Golden State Equity Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $986K | Hold |
19,380
| – | – | 0.18% | 138 |
|
2025
Q1 | $873K | Hold |
19,380
| – | – | 0.17% | 153 |
|
2024
Q4 | $801K | Buy |
19,380
+18,080
| +1,391% | +$748K | 0.15% | 160 |
|
2024
Q3 | $50.7K | Sell |
1,300
-18,630
| -93% | -$727K | 0.03% | 377 |
|
2024
Q2 | $681K | Buy |
+19,930
| New | +$681K | 0.14% | 163 |
|
2023
Q4 | $559K | Buy |
18,930
+950
| +5% | +$28K | 0.14% | 172 |
|
2023
Q3 | $568K | Hold |
17,980
| – | – | 0.16% | 152 |
|
2023
Q2 | $465K | Hold |
17,980
| – | – | 0.13% | 192 |
|
2023
Q1 | $432K | Buy |
+17,980
| New | +$432K | 0.23% | 106 |
|
2022
Q1 | $412K | Hold |
18,730
| – | – | 0.21% | 121 |
|
2021
Q4 | $299K | Buy |
+18,730
| New | +$299K | 0.15% | 128 |
|